In vitro cartilage construct generation from silk fibroin- chitosan porous scaffold and umbilical cord blood derived human mesenchymal stem cells in dynamic culture condition

被引:34
作者
Agrawal, Parinita [1 ]
Pramanik, Krishna [1 ]
Biswas, Amit [1 ]
Patra, Ranjan Ku [2 ]
机构
[1] Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, Odisha, India
[2] Ispat Gen Hosp, Rourkela, Odisha, India
关键词
cartilage construct; spinner flask; silk fibroin; chitosan; mesenchymal stem cells; TISSUE-ENGINEERING APPLICATION; CHONDROGENIC DIFFERENTIATION; ARTICULAR-CARTILAGE; BONE-MARROW; FIBROIN/CHITOSAN SCAFFOLD; ADIPOSE-TISSUE; CHONDROCYTES; REGENERATION; ALGINATE; THERAPY;
D O I
10.1002/jbm.a.36253
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Cartilage construct generation includes a scaffold with appropriate composition to mimic matrix of the damaged tissue on which the stem cells grow and differentiate. In this study, umbilical cord blood (UCB) derived human mesenchymal stem cells (hMSCs) were seeded on freeze dried porous silk-fibroin (SF)/chitosan (CS) scaffolds. Influence of static and dynamic (spinner flask bioreactor) culture conditions on the developing cartilage construct were studied by in-vitro characterization for viability, proliferation, distribution, and chondrogenic differentiation of hMSCs over the scaffold. Constructs developed in spinner flask consisted of 62% live cells, and exhibited 543% more cell density at the core than constructs cultured in static system. Quantification of DNA and glycosaminoglycans accumulation after 21 days showed the progression of chondrogenic differentiation of hMSCs was higher in dynamic culture compared to static one. In constructs generated under dynamic condition, histology staining for proteoglycan matrix, and fluorescence staining for collagen-II and aggrecan showed positive correlation between early and late stage chondrogenic markers, which was further confirmed by quantitative PCR analysis, showing low collagen-I expression and highly expressed Sox9, collagen-II and aggrecan. The present study demonstrated that construct generated by combining 3D SF/CS scaffold with UCB-hMSCs under dynamic condition using spinner flask bioreactor can be used for cartilage tissue regeneration for future medical treatments. (c) 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 397-407, 2018.
引用
收藏
页码:397 / 407
页数:11
相关论文
共 35 条
[1]   Chitosan-poly(vinyl alcohol) nanofibers by free surface electrospinning for tissue engineering applications [J].
Agrawal, Parinita ;
Pramanik, Krishna .
TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2016, 13 (05) :485-497
[2]   Adhesion, migration and mechanics of human adipose-tissue-derived stem cells on silk fibroin-chitosan matrix [J].
Altman, Andrew M. ;
Gupta, Vishal ;
Rios, Carmen N. ;
Alt, Eckhard U. ;
Mathur, Anshu B. .
ACTA BIOMATERIALIA, 2010, 6 (04) :1388-1397
[3]   Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds [J].
Awad, HA ;
Wickham, MQ ;
Leddy, HA ;
Gimble, JM ;
Guilak, F .
BIOMATERIALS, 2004, 25 (16) :3211-3222
[4]   Chondrogenic differentiation of rat MSCs on porous scaffolds of silk fibroin/chitosan blends [J].
Bhardwaj, Nandana ;
Kundu, Subhas C. .
BIOMATERIALS, 2012, 33 (10) :2848-2857
[5]   Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood [J].
Bieback, K ;
Kern, S ;
Klüter, H ;
Eichler, H .
STEM CELLS, 2004, 22 (04) :625-634
[6]   Tissue engineering and cell therapy of cartilage and bone [J].
Cancedda, R ;
Dozin, B ;
Giannoni, P ;
Quarto, R .
MATRIX BIOLOGY, 2003, 22 (01) :81-91
[7]   A silk fibroin/chitosan scaffold in combination with bone marrow-derived mesenchymal stem cells to repair cartilage defects in the rabbit knee [J].
Deng, Jiang ;
She, Rongfeng ;
Huang, Wenliang ;
Dong, Zhijun ;
Mo, Gang ;
Liu, Bin .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2013, 24 (08) :2037-2046
[8]   Chitosan: A versatile biopolymer for orthopaedic tissue-engineering [J].
Di Martino, A ;
Sittinger, M ;
Risbud, MV .
BIOMATERIALS, 2005, 26 (30) :5983-5990
[9]   Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[10]   Mesenchymal progenitor cells in human umbilical cord blood [J].
Erices, A ;
Conget, P ;
Minguell, JJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) :235-242